Consolidated Statements of Operations and Comprehensive Earnings and Loss (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 120,078	$ 123,269	$ 133,197
Less provision for bad debts of Healthcare Facilities Segment	11,853	10,080	12,849
Net Revenues	108,225	113,189	120,348
Costs and expenses:
Cost of goods sold	22,363	26,073	27,835
Salaries, wages and benefits	52,660	52,115	53,563
Provision for bad debts of Specialty Pharmacy Segment	514	605	1,268
Supplies	9,095	8,428	9,747
Purchased services	7,480	7,958	8,551
Other operating expenses	15,400	15,661	16,520
Rents and leases expense	1,918	2,191	2,370
Impairment of property, plant and equipment	789	0	0
Impairment of goodwill and intangible assets	0	931	13,347
Depreciation and amortization	4,048	4,365	5,344
Electronic Health Records incentive payments	(4,947)	(7,294)	(277)
Operating profit (loss)	(1,095)	2,156	(17,920)
Other income (expense):
Interest expense	(1,797)	(4,391)	(7,433)
Interest income	1	14	5
Loss on sale of assets	0	(20)	0
Loss from continuing operations before income taxes	(2,891)	(2,241)	(25,348)
Income tax benefit	(1,306)	(565)	(9,072)
Loss from continuing operations	(1,585)	(1,676)	(16,276)
Earnings from discontinued operations, net of income taxes	6,073	2,757	173
Net earnings (loss)	4,488	1,081	(16,103)
Other comprehensive income (loss)	91	(219)	23
Comprehensive income (loss)	$ 4,579	$ 862	$ (16,080)
Continuing operations:
Basic	$ (0.17)	$ (0.18)	$ (2.01)
Diluted	$ (0.17)	$ (0.18)	$ (2.01)
Discontinued operations:
Basic	$ 0.64	$ 0.29	$ 0.02
Diluted	$ 0.64	$ 0.29	$ 0.02
Net earnings (loss):
Basic	$ 0.48	$ 0.12	$ (1.99)
Diluted	$ 0.48	$ 0.12	$ (1.99)
Weighted-average common shares outstanding:
Basic	9,445	9,350	8,094
Diluted	9,445	9,350	8,094